Your Notifications
All done, no notifications

What is ANCA-Associated Vasculitis?

ANCA-associated vasculitis (AAV) is a group of rare autoimmune diseases that cause inflammation and damage to small blood vessels. The main forms are granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Inflammation can affect multiple organs, particularly the kidneys, lungs, upper airways, skin, nerves, and, in some patients, the eyes or gastrointestinal system. AAV is often associated with antibodies called antineutrophil cytoplasmic antibodies (ANCA), although not every patient with AAV is ANCA-positive.

What is the Importance of Timely Treatment?

Early diagnosis and treatment matter because active vasculitis can rapidly damage organs, especially the kidneys and lungs. Severe disease can lead to rapidly progressive kidney failure, pulmonary haemorrhage or other life-threatening complications. Treatment aims to control inflammation, achieve remission and prevent permanent organ damage and relapses. Current guidelines recommend prompt induction therapy for organ- or life-threatening disease.

What are the Common Symptoms of ANCA-Associated Vasculitis?

  • Persistent fatigue and weakness
  • Fever or unexplained weight loss
  • Joint and muscle pain
  • Skin rashes or purpura, particularly on the legs
  • Sinusitis, nasal congestion or recurrent nose problems
  • Nosebleeds or nasal crusting
  • Cough or shortness of breath
  • Coughing up blood in severe lung involvement
  • Blood or protein in the urine
  • Swelling of the legs or feet
  • Reduced kidney function
  • Numbness, tingling or weakness due to nerve involvement
  • Eye redness, pain or vision changes
  • Gastrointestinal pain or other organ-specific symptoms

Causes and Risk Factors of ANCA-Associated Vasculitis

Causes

  • The exact cause of ANCA-associated vasculitis is not fully understood. It is believed to result from an abnormal immune response in which activated immune cells and, in many patients, ANCA antibodies contribute to inflammation and injury of small blood vessels.
  • Genetic susceptibility and environmental or infectious triggers may contribute to disease development.

Risk Factors

  • Genetic susceptibility
  • Family history of autoimmune or vasculitic disease
  • Exposure to certain environmental or occupational factors
  • Some infections or medications, particularly in selected forms of ANCA-positive vasculitis
  • Increasing age for certain AVV subtypes

Latest Research and Technologies in the Treatment of ANCA-Associated Vasculitis in Thailand

  • Current research is focusing on targeted B-cell therapy, complement inhibition, reduced glucocorticoid exposure, improved biomarkers for disease activity, and personalised strategies to reduce relapse and treatment-related complications. Approaches aim to balance remission, relapse prevention and treatment toxicity through regular assessment of kidney function, urine findings, blood counts and other relevant clinical markers.

Treatment options for ANCA-Associated Vasculitis

Plasmapheresis : Consider plasma exchange for selected patients with severe kidney disease or specific high-risk presentations, after assessing potential benefits and risks.


Cost Start From 700Explore Options

  • Clinical assessment:
    • Medical and Physical Evaluation: Review a detailed medical and medication history and perform a physical examination to identify systemic and organ-specific manifestations. Assessment may include symptoms and signs involving the kidneys, lungs, nerves, skin, eyes, and ENT system to help determine the pattern and severity of disease.
    • Kidney and Laboratory Assessment: Assess kidney function with serum creatinine and estimated GFR, and perform urinalysis to detect blood or protein in the urine.
    • ANCA Testing: Blood testing for antineutrophil cytoplasmic antibodies (ANCA), can support the diagnosis and provide information about the AAV subtype.
    • Tissue Biopsy: Kidney or other tissue biopsy may be recommended when the diagnosis remains uncertain or when confirmation and assessment of organ damage are important.
  • Imaging Tests:
    • Chest X-ray: May identify lung infiltrates, nodules or other pulmonary abnormalities.
    • High-resolution chest CT: Provides detailed assessment of pulmonary nodules, infiltrates, haemorrhage, or interstitial changes.
    • CT of the Sinuses: May be used in GPA when persistent upper-airway or sinus involvement is suspected.
    • Kidney Ultrasound: Helps assess kidney size and exclude structural causes of kidney dysfunction.
    • MRI: May be used when neurological, orbital or other organ involvement requires detailed imaging.
    • Echocardiography: Consider when cardiac involvement or pulmonary hypertension is suspected.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services to support ANCA-associated vasculitis patients in Thailand. These services include:

  • Physiotherapy: Helps maintain muscle strength, mobility, balance and endurance in patients affected by weakness, nerve involvement or prolonged illness.
  • Occupational Therapy: Supports independence with daily activities when fatigue, weakness, neuropathy or joint problems affect function.
  • Respiratory Rehabilitation: Selected patients with significant lung involvement may benefit from breathing exercises, pulmonary rehabilitation and monitored physical activity.
  • Neurological Rehabilitation: Patients with peripheral nerve involvement may require gait training, balance exercises and targeted rehabilitation.
  • Medicines for ANCA-associated vasculitis aim to suppress abnormal immune activity, induce remission and prevent relapse. Doctors may prescribe additional medicines to prevent infection, control blood pressure, manage kidney complications, protect bones, or address other treatment-related risks. Specialists must closely monitor medication selection and dosing because immunosuppressive therapy can increase the risk of infections and other adverse effects.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for ANCA-Associated Vasculitis in Thailand

MALI Interdisciplinary Hospital: Top Doctors, and Reviews
MALI Interdisciplinary Hospital

Bangkok, Thailand

MALI Interdisciplinary Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Operating Room
  • X-Ray Department
  • Laboratory
  • Inpatient Department
  • Emergency Department
Message Us
Bangpakok 9 International Hospital: Top Doctors, and Reviews
Bangpakok 9 International Hospital

Bangkok, Thailand

Bangpakok 9 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • It would be prudent to summarise the Medical Services provided at the Bangpakok 9 International Hospital (BPK 9), Bangkok, Thailand:
  • Cosmetic Dentistry
  • Dental Implants
  • Electrocardiogram (EKG or ECG)
  • Exercise Stress Test
  • Health Screening
  • Laser Vagina Firming
  • Pediatric Physical Therapy
  • Perfect Slim by Vela II
  • Physical Therapy for Musculoskeletal
  • Prosthodontics
  • The Medical Services are also inclusive of the International Patient Services such as the ones listed here:
  • Thai, English, French, Arabic, Chinese, Myanmar, Cambodia, Bangladeshi, Bahasa and Tagalog are the languages in which there are Translation services available for International Patients.
  • Visa extension related assistance
  • International health insurance related assistance
  • Embassy and international organizations related assistance
  • A variety of meals of choice for International Patients
  • Email consultation services
  • Transfer to either airport and/or hotels
  • Prayer room
  • Four different types of rooms are available such as Deluxe room, two kinds of suites, and a VIP suite.
  • Hospital facilities like The Coffee shop, Food Hall, Cafe and Medical Spa.
  • Complete health and safety protocols are maintained in the various Medical Centers some of whom are as follows:
  • Aesthetic Center
  • 24 Hour Emergency Center
  • Allergy Center
  • Breast Center
  • bSmart Center
  • Checkup Center
  • Dental Center,
  • Happy Long Life Center
  • Medical Fitness Center
  • Psychiatric Center
  • Rehabilitation Center
  • Sleep Disorders Center
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Thailand for ANCA-Associated Vasculitis Treatment?

  • Multidisciplinary Specialist Care: Patients can access rheumatologists, nephrologists, pulmonologists, neurologists and other specialists depending on the organs involved.
  • Advanced Diagnostic Facilities: Major centres may provide ANCA testing, kidney biopsy, advanced imaging, pulmonary evaluation and comprehensive laboratory monitoring.
  • Modern Immunosuppressive Treatment: Specialised centres may offer steroid-sparing approaches and other treatments according to clinical indications.
  • Comprehensive Kidney and Organ Care: Hospitals with nephrology and critical-care services can manage severe kidney disease, pulmonary complications and other organ-threatening manifestations.
  • Rehabilitation and International Patient Support: Rehabilitation, nutritional counselling, follow-up care and international-patient coordination can be integrated into the treatment pathway.

Frequently Asked Questions

Recovery varies by AAV type, inflammation severity, organs affected, and response to treatment. Active disease may improve over weeks to months, but long-term maintenance treatment and monitoring are often required because relapses can occur.

Many patients can walk normally, particularly when the disease does not significantly affect the nerves, muscles or joints. Peripheral neuropathy, muscle weakness, joint inflammation or prolonged illness may affect mobility and may require physiotherapy.

Major Thai centres may provide ANCA testing, kidney biopsy, advanced CT and MRI, pulmonary investigations, intensive monitoring and modern immunosuppressive treatments for appropriately selected patients.

Many major Thai hospitals have international-patient departments that can assist with medical records, specialist consultations, treatment coordination, travel arrangements, accommodation and follow-up care.

Consider a centre with experience in systemic autoimmune diseases and access to rheumatology, nephrology, pulmonology, pathology, radiology and critical-care services. For kidney involvement, experience in vasculitis-related kidney disease and kidney biopsy is particularly important.

No single success rate applies to all patients with ANCA-associated vasculitis. Outcomes depend on the AAV subtype, disease severity, organs affected, extent of permanent damage, response to treatment and occurrence of relapses. Early treatment can help control active inflammation and reduce the risk of irreversible organ damage.

Rheumatologists, nephrologists and other specialists in specialised centres manage ANCA-associated vasculitis as part of multidisciplinary autoimmune and systemic inflammatory disease care. Patients should consider a centre with experience managing the affected organs.

Treatment risks depend on the medicines used and the patient's overall health. Immunosuppressive treatments can increase infection risk and may cause blood-count abnormalities, liver problems, gastrointestinal effects, or other medicine-specific complications. Untreated active vasculitis can also cause serious organ damage.

Coughing up blood, severe or worsening shortness of breath, markedly reduced urine output, rapidly worsening kidney function, sudden visual changes or new severe neurological symptoms require urgent assessment. Severe symptoms may indicate life- or organ-threatening disease.

Yes, in some cases. Severe or prolonged inflammation may lead to permanent kidney damage, nerve injury, hearing or vision problems, or lung complications. Early diagnosis and appropriate treatment can reduce the risk of irreversible damage, but recovery depends on the extent of existing injury.

Yes. Fatigue, pain, reduced mobility, organ complications, treatment side effects and concerns about relapse can affect daily activities, employment and emotional well-being. Individualised medical care, supportive services, and rehabilitation, when appropriate, can help patients maintain function and quality of life.

Untreated active AAV can cause progressive organ damage. Serious complications include rapidly progressive kidney inflammation, kidney failure, pulmonary haemorrhage and nerve or other organ injury. Some complications can be life-threatening, so suspected AAV requires prompt medical assessment and appropriate treatment.

No established way exists to prevent most cases of AAV because its underlying causes are not fully understood. When drug-induced vasculitis is suspected, a clinician should review possible medication triggers and advise on appropriate changes. For people already diagnosed with AAV, adherence to treatment, regular monitoring, and early reporting of possible relapse symptoms can help reduce complications.

AAV can affect people of different ages and backgrounds, although the frequency and clinical pattern vary by subtype. Clinicians more often diagnose GPA and MPA in adults, while EGPA is associated with asthma and eosinophilia. Genetic and environmental factors may contribute to susceptibility, but no single identifiable cause is usually identified.

Author

Pragun Gupta
Pragun Gupta

Doctor of Pharmacy

1 Year of Experience

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance.

As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.

View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026